Hormonal treatment in infertile men with hypogonadotropic hypogonadism

[madman]

To view this content we will need your consent to set third party cookies.
For more detailed information, see our cookies page.

Accept third party cookies

Organised by the European School of Urology and the EAU Section of Andrological Urology , this recording centres on hormone treatment in infertile men which is a challenging issue as the treatment can have both beneficial and harmful effects. Spermatogenesis is under hormonal regulation involving not only the testis but also the pituitary gland and the hypothalamus. Testosterone deficiency is seen in 20-30% of all infertile men.

This recording will shed a light on current well-established and new indications for hormone treatment in men with fertility problems. Experts in the field will provide a comprehensive overview of options and limitations regarding reproductive hormone treatment, and when and how to give it.


Speakers:

Prof. C. Bettocchi (IT)
Prof. Dr. A. Giwercman (SE)
Ass. Prof. Z. Kopa (HU)
Prof. Dr. G.I. Russo (IT)
Prof. Dr. T. Diemer (DE)
Prof. M. Cosentino (IT)

 

[madman]

 

[madman]

 

[madman]

 

[madman]

 

[madman]

 

[madman]

* An in vivo kinetic study in healthy men revealed that the total time to produce an ejaculated sperm ranges from 42 to 76 days

 

[madman]

 

[madman]

Hormonal Treatment for Male Infertility: On -label and Off- label

12:12-21:46 Here is a summary of the "UROwebinar: Male infertility An updated work up" by the European School of Urology in 10 bullet points: Introduction to Webinar: The webinar, led by Mary Dinkan, covers the latest advancements in diagnostics and treatment of male reproductive health...

www.excelmale.com